UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | F | G | H | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | Y
Number of items: 193.

A

Adams, MJ; Donohoe, S; Mackie, IJ; Machin, SJ; (2001) Anti-tissue factor pathway inhibitor activity in patients with primary antiphospholipid syndrome. BRIT J HAEMATOL , 114 (2) 375 - 379.

Adeyemo, D; Imtiaz, F; Toffa, S; Lowdell, M; Wickremasinghe, RG; Winslet, M; (2001) Antioxidants enhance the susceptibility of colon carcinoma cells to 5-fluorouracil by augmenting the induction of the bax protein. CANCER LETT , 164 (1) 77 - 84.

Ahmed, F; Ings, SJ; Pizzey, A; Fahey, A; Blundell, M; Hardy, SJ; Thrasher, A; ... Yong, KL; + view all (2001) Cytokine exposure impairs short-term homing of CD34(+) cells in SCID/NOD mice: Influence of cell cycle status. BLOOD , 98 (11) 644A - 644A.

Allen, AJ; Gale, RE; Harrison, CN; Machin, SJ; Linch, DC; (2001) Lack of pathogenic mutations in the 5'-untranslated region of the thrombopoietin gene in patients with non-familial essential thrombocythaemia. European Journal of Haematology , 67 (4) pp. 232-237.

Allen, AJR; Gale, RE; Harrison, CN; Machin, SJ; Linch, DC; (2001) Lack of pathogenic mutations in the 5 '-untranslated region of the thrombopoietin gene in patients with non-familial essential thrombocythaemia. EUR J HAEMATOL , 67 (4) 232 - 237.

Ancliff, P.J.; Gale, R.E.; Liesner, R.; Hann, I.M.; Linch, D.C.; (2001) Mutations in the ELA2 gene encoding neutrophil elastase are present in most patients with sporadic severe congenital neutropenia but only in some patients with the familial form of the disease. Blood , 98 (9) pp. 2645-2650. 10.1182/blood.V98.9.2645.

Ancliff, PJ; Blundell, MP; Gale, RE; Liesner, R; Hann, IM; Thrasher, AJ; Linch, DC; (2001) Activating mutations in theWiskott Aldrich syndrome protein may define a sub-group of severe congenital neutropenia (SCN) with specific and unusual laboratory features. BLOOD , 98 (11) 439A - 440A.

Ancliff, PJ; Gale, RE; Hann, IM; Strobel, S; Linch, DC; (2001) Paternal mosaicism proves the pathogenic nature of mutations in neutrophil elastase in severe congenital neutropenia. BLOOD , 98 (11) 439A - 439A.

Ancliff, PJ; Gale, RE; Liesner, R; Hann, IM; Linch, DC; (2001) Mutations in the ELA2 gene encoding neutrophil elastase are present in most patients with sporadic severe congenital neutropenia but only in some patients with the familial form of the disease. BLOOD , 98 (9) 2645 - 2650.

Anderson, LJ; Holden, S; Davis, B; Prescott, E; Charrier, CC; Bunce, NH; Firmin, DN; ... Pennell, DJ; + view all (2001) Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. EUR HEART J , 22 (23) 2171 - 2179. 10.1053/euhj.2001.2822.

Antin, JH; Childs, R; Filipovich, AH; Giralt, S; Mackinnon, S; Spitzer, T; Weisdorf, D; (2001) Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: Recommendations from a Workshop at the 2001 Tandem Meetings. BIOL BLOOD MARROW TR , 7 (9) 473 - 485.

Ardeshna, KM; Smith, P; Linch, DC; BNLI, ; (2001) The long-term impact of a watch and wait policy vs immediate systemic treatment for asymptomatic advanced stage indolent non Hodgkins lymphoma: Results of a British national lymphoma randomised trial. BRIT J CANCER , 85 2 - 2.

Arnold, J; Cohen, H; (2001) Erratum: Heparin-induced skin necrosis (British Journal of Haematology 111:4 (991-992)). British Journal of Haematology , 112 (4) 1091-. 10.1046/j.1365-2141.2001.02718.x.

Arnold, T; Holmes, Z; Pickering, W; Farmer, C; Regan, L; Cohen, H; (2001) Anti-beta 2 glycoprotein 1 and anti-annexin V antibodies in women with recurrent miscarriage. BRIT J HAEMATOL , 113 (4) 911 - 914.

Aubert, G; Hassan-Walker, AF; Madrigal, JA; Emery, VC; Morte, C; Grace, S; Koh, MBC; ... Travers, PJ; + view all (2001) Cytomegalovirus-specific cellular immune responses and viremia in recipients of allogeneic stem cell transplants. J INFECT DIS , 184 (8) 955 - 963.

B

Bennett, CL; Misslitz, A; Colledge, L; Aebischer, T; Blackburn, CC; (2001) Silent infection of bone marrow-derived dendritic cells by Leishmania mexicana amastigotes. EUROPEAN JOURNAL OF IMMUNOLOGY , 31 (3) pp. 876-883. 10.1002/1521-4141(200103)31:3<876::AID-IMMU876>3.0.CO;2-I.

Berger, LA; Warwick, R; Mehta, A; (2001) Isolated Candida infection of the pterygoid muscles in a patient with Gaucher's disease. American Journal of Roentgenology , 176 1332-.

Borras, FE; Matthews, NC; Lowdell, MW; Navarrete, CV; (2001) Identification of both myeloid CD11c(+) and lymphoid CD11c(-) dendritic cell subsets in cord blood. BRIT J HAEMATOL , 113 (4) 925 - 931.

Borràs, FE; Matthews, NC; Lowdell, MW; Navarrete, CV; (2001) Both lymphoid and myeloid subsets of dendritic cells are present in cord blood. European Journal of Immunogenetics , 28 (2) 259-.

C

Cardigan, RA; Crook, M; Mackie, IJ; Machin, SJ; (2001) Plasma levels of factor XIIa and factor VIIa are increased but not related in primary hyperlipidaemia. BLOOD COAGUL FIBRIN , 12 (3) 187 - 192.

Cardigan, RA; Mackie, IJ; Gippner-Steppert, C; Jochum, M; Royston, D; Gallimore, MJ; (2001) Determination of plasma aprotinin levels by functional and immunologic assays. BLOOD COAGUL FIBRIN , 12 (1) 37 - 42.

Chakrabarti, S; Mackinnon, S; Kottaridis, P; Hale, G; Osman, H; Peggs, K; Fegan, C; ... Milligan, D; + view all (2001) Community respiratory virus and adenovirus infections in nonmyeloablative transplant recipients conditioned with. Campath-1H: High incidence but low mortality. In: BLOOD. (pp. 392A - 392A). AMER SOC HEMATOLOGY

Chakraverty, R; Rabin, N; Peggs, K; Robinson, S; Duncan, JR; Yong, K; (2001) Dermatomyositis and sarcoid-like reaction associated with multiple myeloma treated effectively by high-dose chemotherapy and autologous peripheral blood stem cell transplantation. BONE MARROW TRANSPL , 27 (11) 1215 - 1217.

Chakraverty, RK; Kearsey, JM; Oakley, TJ; Grenon, M; Ruiz, MADLT; Lowndes, NF; Hickson, ID; (2001) Topoisomerase III acts upstream of Rad53p in the S-Phase DNA damage checkpoint. MOLECULAR AND CELLULAR BIOLOGY , 21 (21) pp. 7150-7162. 10.1128/MCB.21.21.7150-7162.2001.

Chatterjee, R; Kottaridis, PD; McGarrigle, HH; Eliahoo, J; McKeag, N; Mackinnon, S; Goldstone, AH; (2001) Patterns of Leydig cell insufficiency in adult males following bone marrow transplantation for haematological malignancies. BONE MARROW TRANSPL , 28 (5) 497 - 502.

Chitolie, A; Lawrie, AS; Mackie, IJ; Harrison, P; Machin, SJ; (2001) The impact of oral anticoagulant therapy, factor VIII level and quality of factor V-deficient plasma on three commercial methods for activated protein C resistance. BLOOD COAGUL FIBRIN , 12 (3) 179 - 186.

Clark, RE; Dodi, IA; Hill, SC; Lill, JR; Aubert, G; Macintyre, AR; Rojas, J; ... Madrigal, JA; + view all (2001) Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein. Blood , 98 (10) pp. 2887-2893. Green open access
file

Cohen, H; (2001) Lack of an association between the -455F/A b-fibrinogen gene polymorphism and pregnancy complications. In: (Proceedings) International society of thrombosis and haemostasis.

Cohen, H; (2001) Management of Jehovah's Witness patients with haematological problems. [Lecture]. Presented at: British society for haematology annual scientific meeting, Harrogate.

Cohen, H; (2001) SHOT: the future. In: (Proceedings) SHOT annual symposium.

Cook, DG; Cappuccio, FP; Atkinson, RW; Wicks, PD; Chitolie, A; Nakandakare, ER; Sagnella, GA; (2001) Ethnic differences in fibrinogen levels: The role of environmental factors and the beta-fibrinogen gene. AM J EPIDEMIOL , 153 (8) 799 - 806.

Cox, ST; McWhinnie, AJ; Baker, FA; Stubbins, MJ; Allen, CJ; Holman, R; Madrigal, JA; (2001) Identification of HLA-A*2306. Tissue Antigens , 57 (1) pp. 73-75.

Cox, ST; McWhinnie, AJ; Koester, RP; Heine, U; Holman, R; Madrigal, JA; Little, AM; (2001) Further diversity at HLA-A and -B loci identified in Afro- Caribbean potential bone marrow donors. Tissue Antigens , 57 (1) pp. 70-72.

Cox, ST; Tavarozzi, F; McWhinnie, A; Hoddinott, MA; Calvert, A; Baker, F; Madrigal, JA; (2001) HLA-B*4034 identified in a UK Caucasoid potential bone marrow donor. Immunogenetics , 53 (1) pp. 43-44.

D

D'Sa, SP; Peggs, KS; Thuraisundaram, D; Fox, R; Goldstone, AH; Mackinnon, S; Yong, KL; (2001) CAMPATH-1H-containing nonmyeloablative allogeneic stem cell transplantation for myeloma results in delayed T cell reconstitution and a high incidence of viral infections, but low infection-related mortality. In: BLOOD. (pp. 203A - 203A). AMER SOC HEMATOLOGY

Donohoe, S; Mackie, IJ; Isenberg, D; Machin, SJ; (2001) Anti-prothrombin antibodies: Assay conditions and clinical associations in the anti-phospholipid syndrome. British Journal of Haematology , 113 (2) pp. 544-549. 10.1046/j.1365-2141.2001.02716.x.

Donohoe, S; Mackie, IJ; Isenberg, D; Machin, SJ; (2001) Anti-prothrombin antibodies: assay conditions and clinical associations in the anti-phospholipid syndrome. BRIT J HAEMATOL , 113 (2) 544 - 549.

F

Firat, H; Tourdot, S; Ureta-Vidal, A; Scardino, A; Suhrbier, A; Buseyne, F; Rivìere, Y; ... Lemonnier, FA; + view all (2001) Design of a polyepitope construct for the induction of HLA-A0201-restricted HIV 1-specific CTL responses using HLA-A*0201 transgenic, H-2 class I KO mice. Eur J Immunol , 31 (10) pp. 3064-3074. 10.1002/1521-4141(2001010)31:10<3064::AID-IMMU3064gt;3.0.CO;2-L.

G

Gameiro, P; Vieira, S; Carrara, P; Silva, AL; Diamond, J; de Sousa, AB; Mehta, AB; ... Parreira, A; + view all (2001) The PML-RAR alpha transcript in long-term follow-up of acute promyelocytic leukemia patients. Haematologica , 86 (6) 577 - 585. Green open access
file

Glassford, J; Holman, M; Banerji, L; Clayton, E; Klaus, GG; Turner, M; Lam, EW; (2001) Vav is required for cyclin D2 induction and proliferation of mouse B lymphocytes activated via the antigen Receptor. Journal of Biological Chemistry , 276 (44) pp. 41040-41048. Gold open access

Gricks, CS; Rawlings, E; Foroni, L; Madrigal, JA; Amlot, PA; (2001) Somatically mutated regions of immunoglobulin on human B cell lymphomas code for peptides that bind to autologous MHC Class I providing a potential target for cytotoxic T cells. Cancer Research , 61 (13) pp. 5145-5152.

Gricks, CS; Rawlings, E; Foroni, L; Madrigal, JA; Amlot, PL; (2001) Somatically mutated regions of immunoglobulin on human B-cell lymphomas code for peptides that bind to autologous major histocompatibility complex class I, providing a potential target for cytotoxic T cells. Cancer Research , 61 (13) pp. 5145-5152.

Grote, D; Russell, SJ; Cornu, TI; Cattaneo, R; Vile, R; Poland, GA; Fielding, AK; (2001) Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice. BLOOD , 97 (12) pp. 3746-3754. 10.1182/blood.V97.12.3746.

H

Hale, G; Cobbold, S; Novitzky, N; Bunjes, D; Willemze, R; Prentice, HG; Milligan, D; ... CAMPATH Users, ; + view all (2001) CAMPATH-1 antibodies in stem-cell transplantation. CYTOTHERAPY , 3 (3) 145 - 164.

Hancock, BW; Gregory, WM; Cullen, MH; Hudson, GV; Burton, A; Selby, P; Maclennan, KA; ... British Natl Lymphoma Investigatio, ; + view all (2001) ChlVPP alternating with PABIOE is superior to PABIOE alone in the initial treatment of advanced Hodgkin's disease: results of a British National Lymphoma Investigation/Central Lymphoma Group randomized controlled trial. BRIT J CANCER , 84 (10) 1293 - 1300. 10.1054/bjoc.2001.1778.

Hardy, SJ; Shah, SK; Pizzey, A; Khwaja, A; Yong, KL; (2001) Monocytes rescue endothelial cells from apoptosis: Role of nuclear factor kappa B (NF-kappa B). BLOOD , 98 (11) 16A - 16A.

Harris, E; Mahendra, P; McGarrigle, HH; Linch, DC; Chatterjee, R; (2001) Gynaecomastia with hypergonadotrophic hypogonadism and Leydig cell insufficiency in recipients of high-dose chemotherapy or chemoradiotherapy. BONE MARROW TRANSPL , 28 (12) 1141 - 1144.

Hennessy, B; North, J; Deru, A; Llewellyn-Smith, N; Lowdell, MW; (2001) Use of Leu3a/3b for the accurate determination of CD4 subsets for measurement of intracellular cytokines. CYTOMETRY , 44 (2) 148 - 152.

Hennessy, BJ; Orchard, KH; Potter, MN; (2001) Novel approaches to transplant conditioning. HEMATOL ONCOL , 19 (2) 43 - 57.

J

Jackson, G; Taylor, P; Smith, GM; Marcus, R; Smith, A; Chu, P; Littlewood, TJ; ... Wilson, MP; + view all (2001) A multicentre, open, non-comparative phase II study of a combination of fludarabine phosphate, cytarabine and granulocyte colony-stimulating factor in relapsed and refractory acute myeloid leukaemia and de novo refractory anaemia with excess of blasts in transformation. BRITISH JOURNAL OF HAEMATOLOGY , 112 (1) pp. 127-137. 10.1046/j.1365-2141.2001.02551.x.

Jaswon, MS; Linch, DC; (2001) Priming of neutrophil function in the newborn. BRIT J HAEMATOL , 113 (4) 1078 - 1079.

Jones, DT; Ganeshaguru, K; Virchis, AE; Folarin, NI; Lowdell, MW; Mehta, AB; Prentice, HG; ... Wickremasinghe, RG; + view all (2001) Caspase 8 activation independent of Fas (CD95/APO-1) signaling may mediate killing of B-chronic lymphocytic leukemia cells by cytotoxic drugs or gamma radiation. BLOOD , 98 (9) 2800 - 2807.

Jones, DT; Ganeshaguru, K; Virchis, AE; Folarin, NI; Lowdell, MW; Mehta, AB; Prentice, HG; ... Wickremasinghe, RG; + view all (2001) Caspase 8 activation independent of Fas (CD95/APO-1) signaling may mediate killing of B-chronic lymphocytic leukemia cells by cytotoxic drugs or gamma radiation. Blood , 98 (9) pp. 2800-2807. 10.1182/blood.v98.9.2800. Green open access
file

Jooss, K; Gjata, B; Danos, O; von Boehmer, H; Sarukhan, A; (2001) Regulatory function of in vivo anergized CD4(+) T cells. Proc Natl Acad Sci U S A , 98 (15) pp. 8738-8743. 10.1073/pnas.151088898.

Joseph, JE; Harrison, P; Mackie, IJ; Isenberg, DA; Machin, SJ; (2001) Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis. British Journal of Haematology , 115 (2) pp. 451-459. 10.1046/j.1365-2141.2001.03101.x.

Joseph, JE; Harrison, P; Mackie, IJ; Isenberg, DA; Machin, SJ; (2001) Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis. BRIT J HAEMATOL , 115 (2) 451 - 459.

K

Kayyali, R; Porter, JB; Liu, ZD; Davies, NA; Nugent, JH; Cooper, CE; Hider, RC; (2001) Structure-function investigation of the interaction of 1-and 2-substituted 3-hydroxypyridin-4-ones with 5-lipoxygenase and ribonucleotide reductase. J BIOL CHEM , 276 (52) 48814 - 48822. 10.1074/jbc.M109551200. Gold open access

Kelly, PF; Carrington, J; Nathwani, A; Vanin, EF; (2001) RD114-pseudotyped oncoretroviral vectors biological and physical properties. HEMATOPOIETIC STEM CELLS 2000 BASIC AND CLINICAL SCIENCES , 938 262 - 277.

Kottaridis, P; Milligan, D; Chopra, R; Craddock, C; Mahendra, P; Hunter, A; Marsh, J; ... Mackinnon, S; + view all (2001) A non-myeloablative regimen with minimal non relapse mortality for allografting patients with Hodgkin's disease. BONE MARROW TRANSPLANTATION , 27 S66-S66.

Kottaridis, P.D.; Gale, R.E.; Frew, M.E.; Harrison, G.; Langabeer, S.E.; Belton, A.A; Walker, H.; ... Linch, D.C.; + view all (2001) The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials. Blood , 98 (6) pp. 1752-1759. 10.1182/blood.V98.6.1752. Green open access
file

Kottaridis, PD; Gale, RE; Frew, ME; Harrison, G; Langabeer, SE; Belton, AA; Walker, H; ... Linch, DC; + view all (2001) The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials. BLOOD , 98 (6) 1752 - 1759.

Kottaridis, PD; Gale, RE; Langabeer, SE; Linch, DC; (2001) Changes in the pattern of FLT3 mutations between diagnosis and relapse restricts their potential use as markers of minimal residual disease in patients with acute myeloid leukaemia. BLOOD , 98 (11) 717A - 718A.

Kottaridis, PD; Milligan, DW; Chopra, R; Chakraverty, RK; Chakrabarti, S; Robinson, S; Peggs, K; ... Mackinnon, S; + view all (2001) In vivo CAMPATH-1H prevents GvHD following nonmyeloablative stem-cell transplantation. CYTOTHERAPY , 3 (3) 197 - 201.

Kottaridis, PD; Milligan, DW; Chopra, R; Craddock, C; Kyriacou, C; Peggs, K; Cakrabati, S; ... Mackinnon, S; + view all (2001) Non-myeloablative transplantation for patients with Hodgkin's disease: Limited transplant related mortality and possible evidence of a graft versus Hodgkin's effect. In: BLOOD. (pp. 416A - 416A). AMER SOC HEMATOLOGY

Kushner, JP; Porter, JP; Olivieri, NF; (2001) Secondary iron overload. Hematology Am Soc Hematol Educ Program pp. 47-61.

Kyriakou, CA; Milligan, D; Chopra, R; Craddock, C; Chakraverty, R; Mahendra, P; Pettengell, R; ... Mackinnon, S; + view all (2001) Outcome of non-myeloablative stem cell transplantation for NHL is dependent on histology: Good for patients with low grade disease and poor for those with high grade lymphoma. In: BLOOD. (pp. 414A - 414A). AMER SOC HEMATOLOGY

L

Langabeer, SE; Rogers, JR; Harrison, G; Wheatley, K; Walker, H; Bain, BJ; Burnett, AK; ... MRC Adult Leukaemia Working Part, ; + view all (2001) EVI1 expression in acute myeloid leukaemia. BRIT J HAEMATOL , 112 (1) 208 - 211.

Lawrie, AS; Mackie, IJ; Purdy, G; Machin, SJ; (2001) Effect of lupus anticoagulants on INR with different thromboplastins. BLOOD COAGUL FIBRIN , 12 (3) 221 - 221.

Liatsos, C; Mehta, AB; Potter, M; Burroughs, AK; (2001) The hepatologist in the haematologists' camp. Br J Haematol , 113 (3) pp. 567-578. 10.1046/j.1365-2141.2001.02628.x.

Little, AM; Cox, ST; Hoddinott, MA; Ogilvie, H; Bohan, EM; Mufti, GJ; Madrigal, JA; (2001) Identification of HLA-B*0722. Tissue Antigens , 57 (2) pp. 167-168.

Little, AM; Scott, I; Pesoa, S; Marsh, SGE; Arguello, R; Cox, ST; Ramon, D; ... Madrigal, JA; + view all (2001) HLA class I diversity in Kolla Amerindians. HUMAN IMMUNOLOGY , 62 (2) pp. 170-179. 10.1016/S0198-8859(00)00248-2.

Love, EM; Jones, H; Williamson, EM; Cohen, H; (2001) The 1999/2000 annual SHOT report (on behalf of the serious hazards of transfusion steering group).

Lowdell, MW; (2001) Allogeneic immunotherapy of acute leukaemia. CME Bulletin Haematology , 3 (3) pp. 63-66.

Lowdell, MW; (2001) Data analysis in flow cytometry. In: McCarthy, D and Macey, MG, (eds.) Cytometric Analysis of Cell Phenotype and Function. Cambridge University Press: Cambridge.

Lowdell, MW; Lamb, L; Hoyle, C; Velardi, A; Prentice, HG; (2001) Non-MHC-restricted cytotoxic cells: Their roles in the control and treatment of leukaemias. BRIT J HAEMATOL , 114 (1) 11 - 24.

Luzzatto, L; Mehta, AB; Vulliamy, T; (2001) Glucose-6-phosphate Dehydrogenase Deficiency. Metabolic and Molecular Basics of Inherited Disease. In: Scriver, CR and Beaudet, AL and Sly, WS and Valle, D, (eds.) The Metabolic & Molecular Bases of Inherited Diseases. (pp. 4517-4554).

M

Mackie, IJ; Piegsa, K; Furs, SA; Johnson, J; Bounds, W; Machin, SJ; Guillebaud, J; (2001) Protein S levels are lower in women receiving desogestrel-containing combined oral contraceptives (COCs) than in women receiving levonorgestrel-containing COCs at steady state and on cross-over. BRIT J HAEMATOL , 113 (4) 898 - 904.

Maclean, KH; Cleveland, JL; Porter, JB; (2001) Cellular zinc content is a major determinant of iron chelator-induced apoptosis of thymocytes. BLOOD , 98 (13) 3831 - 3839.

Mainwaring, P.N.; Cunningham, D.; Gregory, W.; Hoskin, P.; Hancock, B.; Norton, A.J.; MacLennan, K.; ... Linch, D.; + view all (2001) Mitoxantrone is superior to doxorubicin in a multiagent weekly regimen for patients older than 60 with high-grade lymphoma: results of a BNLI randomized trial of PAdriaCEBO versus PMitCEBO. Blood , 97 (10) pp. 2991-2997. 10.1182/blood.V97.10.2991. Green open access
file

Mallett, SV; Peachey, TD; Sanehi, O; Hazelhurst, G; Mehta, A; (2001) A reducing red blood cell transfusion in elective surgical patients: the role of audit and practice guidelines. Anaesthesia , 55 pp. 1003-1024.

Marchant, WA; Wright, S; Porter, JB; (2001) Coronary artery bypass graft surgery in a patient with haemoglobin SC disease. ANAESTHESIA , 56 (7) pp. 667-669. 10.1046/j.1365-2044.2001.01912-2.x.

Marks, AJ; Cooper, M; Orchard, K; Prentice, HG; Mehta, AB; Hales, G; Wickremasinghe, RG; (2001) Selective killing of leukemia cell lines by antibody-mediated targeting of a cytotoxic amphipathic peptide. BLOOD , 98 (11) 721A - 721A.

Marsh, SG; (2001) Nomenclature for factors of the HLA System, update February 2001. Eur J Immunogenet , 28 (4) pp. 463-464.

Marsh, SG; (2001) Nomenclature for factors of the HLA System, update March 2001. Eur J Immunogenet , 28 (4) 465-.

Marsh, SG; (2001) Nomenclature for factors of the HLA system, update December 2000. Tissue Antigens , 57 (2) pp. 180-183.

Marsh, SG; (2001) Nomenclature for factors of the HLA system, update January 2001. Tissue Antigens , 57 (4) pp. 394-395.

Marsh, SG; (2001) Nomenclature for factors of the HLA system, update November 2000. Tissue Antigens , 57 (2) pp. 177-179.

Marsh, SG; Bodmer, JG; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; ... Terasaki, PI; + view all (2001) Nomenclature for factors of the HLA system, 2000. Hum Immunol , 62 (4) pp. 419-468.

Marsh, SG; Bodmer, JG; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; ... Terasaki, PI; + view all (2001) Nomenclature for factors of the HLA system, 2000. Tissue Antigens , 57 (3) pp. 236-283.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2001) Nomenclature for factors of the HLA system, update April 2001. Tissue Antigens , 58 (3) pp. 207-208.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2001) Nomenclature for factors of the HLA system, update August 2001. Hum Immunol , 62 (12) pp. 1382-1383.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2001) Nomenclature for factors of the HLA system, update February 2001. Tissue Antigens , 57 (6) pp. 551-552.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2001) Nomenclature for factors of the HLA system, update July 2001. Tissue Antigens , 58 (4) pp. 278-279.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2001) Nomenclature for factors of the HLA system, update June 2001. Hum Immunol , 62 (10) pp. 1187-1188.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2001) Nomenclature for factors of the HLA system, update June 2001. Tissue Antigens , 58 (4) pp. 276-277.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2001) Nomenclature for factors of the HLA system, update March 2001. Tissue Antigens , 57 (6) pp. 553-554.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2001) Nomenclature for factors of the HLA system, update May 2001. Hum Immunol , 62 (10) pp. 1185-1186.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2001) Nomenclature for factors of the HLA system, update May 2001. Tissue Antigens , 58 (3) pp. 209-210.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2001) Nomenclature for factors of the HLA system, update October 2000. Tissue Antigens , 57 (1) pp. 93-94.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA system, ; (2001) Nomenclature for factors of the HLA system, update September 2001. Hum Immunol , 62 (12) 1384-.

Marsh, SG; WHO Nomenclature Committee for factors of the HLA system, ; (2001) Nomenclature for factors of the HLA system, Update December 2000. Hum Immunol , 62 (3) pp. 294-296.

Marsh, SG; WHO Nomenclature Committee for factors of the HLA system, ; (2001) Nomenclature for factors of the HLA system, Update November 2000. Hum Immunol , 62 (3) pp. 292-293.

Marsh, SGE; (2001) Nomenclature for factors of the HLA System, update April 2001. EUROPEAN JOURNAL OF IMMUNOGENETICS , 28 (5) p. 557. 10.1046/j.1365-2370.2001.00295.x.

Marsh, SGE; (2001) Nomenclature for factors of the HLA System, update August 2000. EUROPEAN JOURNAL OF IMMUNOGENETICS , 28 (1) pp. 101-102. 10.1046/j.1365-2370.2001.00255.x.

Marsh, SGE; (2001) Nomenclature for factors of the HLA System, update August 2001. EUROPEAN JOURNAL OF IMMUNOGENETICS , 28 (6) pp. 599-600. 10.1046/j.1365-2370.2001.00306.x.

Marsh, SGE; (2001) Nomenclature for factors of the HLA System, update December 2000. EUROPEAN JOURNAL OF IMMUNOGENETICS , 28 (2) pp. 191-193.

Marsh, SGE; (2001) Nomenclature for factors of the HLA System, update January 2001. EUROPEAN JOURNAL OF IMMUNOGENETICS , 28 (3) pp. 439-440. 10.1046/j.1365-2370.2001.00278.x.

Marsh, SGE; (2001) Nomenclature for factors of the HLA System, update July 2001. EUROPEAN JOURNAL OF IMMUNOGENETICS , 28 (6) p. 597. 10.1046/j.1365-2370.2001.00298.x.

Marsh, SGE; (2001) Nomenclature for factors of the HLA System, update June 2001. EUROPEAN JOURNAL OF IMMUNOGENETICS , 28 (5) p. 561. 10.1046/j.1365-2370.2001.00297.x.

Marsh, SGE; (2001) Nomenclature for factors of the HLA System, update May 2001. EUROPEAN JOURNAL OF IMMUNOGENETICS , 28 (5) p. 559. 10.1046/j.1365-2370.2001.00296.x.

Marsh, SGE; (2001) Nomenclature for factors of the HLA System, update November 2000. EUROPEAN JOURNAL OF IMMUNOGENETICS , 28 (2) pp. 189-190.

Marsh, SGE; (2001) Nomenclature for factors of the HLA System, update October 2000. EUROPEAN JOURNAL OF IMMUNOGENETICS , 28 (2) pp. 187-188. 10.1046/j.1365-2370.2001.00257.x.

Marsh, SGE; (2001) Nomenclature for factors of the HLA System, update September 2000. EUROPEAN JOURNAL OF IMMUNOGENETICS , 28 (1) p. 103. 10.1046/j.1365-2370.2001.00256.x.

Marsh, SGE; Bodmer, JG; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, S; Erlich, HA; ... Terasaki, PI; + view all (2001) Nomenclature for factors of the HLA system, 2000. EUROPEAN JOURNAL OF IMMUNOGENETICS , 28 (3) pp. 377-424. 10.1046/j.1365-2370.2001.00268.x.

McCloskey, KE; Zborowski, M; Chalmers, JJ; (2001) Measurement of CD2 expression levels of IFN-alpha-treated fibrosarcomas using cell tracking velocimetry. Cytometry , 44 (2) pp. 137-147.

Mehta, A; Guidelines, C; (2001) Diagnosis and management of myeloma. British Journal of Haematology , 115 pp. 522-540.

Mehta, AB; (2001) Anaemia. In: Bloom, SL, (ed.) Practical Gastroenterology. (pp. 321-330). Martin Dunitz Ltd

Mehta, AB; Burroughs, AK; (2001) Thrombopoietin concentration after orthotopic liver transplantation. British Journal of Haematology , 114 (4) pp. 960-961.

Mehta, AB; Hennessy, B; (2001) Gastrointestinal problems in haematological patients. In: Bloom, SL, (ed.) Practical Gastroenterology. (pp. 55-70). Martin Dunitz Ltd

Mehta, ABBAK; (2001) Thrombopoietin concentration after orthotopic liver. British Journal of Haematology , 114 (4) pp. 960-961.

Milton, NG; Mayor, NP; Rawlinson, J; (2001) Identification of amyloid-beta binding sites using an antisense peptide approach. Neuroreport , 12 (11) pp. 2561-2566. 10.1097/00001756-200108080-00054.

Mollapour, E; Linch, DC; Roberts, PJ; (2001) Activation and priming of neutrophil nicotinamide adenine dinucleotide phosphate oxidase and phospholipase A(2) are dissociated by inhibitors of the kinases p42(ERK2) and p38(SAPK) and by methyl arachidonyl fluorophosphonate, the dual inhibitor of cytosol. Blood , 97 (8) pp. 2469-2477.

Mollapour, E; Linch, DC; Roberts, PJ; (2001) Activation and priming of neutrophil nicotinamide adenine dinucleotide phosphate oxidase and phospholipase A(2) are dissociated by inhibitors of the kinases p42(ERK2) and p38(SAPK) and by methyl arachidonyl fluorophosphonate, the dual inhibitor of cytosolic and calcium-independent phospholipase A(2). BLOOD , 97 (8) 2469 - 2477.

Moreira, I; Papaionnou, M; Mortuza, FY; Gameiro, P; Palmisano, GL; Swanton, S; Harrison, CJ; ... Foroni, L; + view all (2001) Oligoclonality: an insight into the biology of acute lymphoblastic leukaemia. Leukemia , 15 (10) pp. 1527-1533.

Morris, E; Naik, P; Goldstone, A; Linch, D; Mackinnon, S; Singer, M; (2001) 5 year experience of intensive care for critically ill patients following chemotherapy or bone marrow transplantation: Who should go to ICU? BLOOD , 98 (11) 432A - 433A.

Morris, E; Rebello, P; Thomson, K; Peggs, K; Kyriakou, C; Goldstone, A; Linch, D; ... Hale, G; + view all (2001) Pharmacokinetics of Campath-1H in vivo T cell depletion in non-myeloablative allogeneic transplants: Relevance for early adoptive immunotherapy. In: BLOOD. (pp. 478A - 478A). AMER SOC HEMATOLOGY

Mortuza, FY; Moreira, IM; Papaioannou, M; Gameiro, P; Coyle, LA; Gricks, CS; Amlot, P; ... Foroni, L; + view all (2001) Immunoglobulin heavy-chain gene rearrangement in adult acute lymphoblastic leukemia reveals preferential usage of J(H)-proximal variable gene segments. BLOOD , 97 (9) pp. 2716-2726. 10.1182/blood.V97.9.2716.

Mundee, Y; Bigelow, NC; Davis, BH; Porter, JB; (2001) Flow cytometric method for simultaneous assay of foetal haemoglobin containing red cells, reticulocytes and foetal haemoglobin containing reticulocytes. CLIN LAB HAEMATOL , 23 (3) 149 - 154.

Mundee, Y; Bigelow, NC; Davis, BH; Porter, JB; (2001) Technical Report: Triple-Colour Staining Flow Cytometry for Co-Distribution of Thrombospondin Receptor (CD36), Ribonucleic Acid (RNA) and Fetal Haemoglobin (HbF) in Sickle Red Blood Cells. Hematology , 6 (1) pp. 91-100. 10.1080/10245332.2001.11746558.

Mundee, Y.; (2001) Red cell adhesion molecules, foetal haemoglobin and endothelial factors in sickle cell disorders. Doctoral thesis , University of London. Green open access
file

Murphy, MF; Wallington, TB; Kelsey, P; Boulton, F; Bruce, M; Cohen, H; Duguid, J; ... British Committee for Standards in Haematology, Blood Transfusio, ; + view all (2001) Guidelines for the clinical use of red cell transfusions. Br J Haematol , 113 (1) pp. 24-31. 10.1046/j.1365-2141.2001.02701.x.

N

Nathwani, AC; Davidoff, A; Hanawa, H; Zhou, JF; Vanin, EF; Nienhuis, AW; (2001) Factors influencing in vivo transduction by recombinant adeno-associated viral vectors expressing the human factor IX cDNA. Blood , 97 (5) pp. 1258-1265. 10.1182/blood.v97.5.1258. Green open access
file

New, HV; Harrison, CN; Rodeck, CH; de Silva, M; Cohen, H; (2001) Antenatal antibody screening. LANCET , 357 (9264) 1295 - 1295.

Nitu-Whalley, IC; Griffioen, A; Harrington, C; Lee, CA; (2001) Retrospective review of the management of elective surgery with desmopressin and clotting factor concentrates in patients with von Willebrand disease. AM J HEMATOL , 66 (4) 280 - 284.

O

Orleans-Lindsay, JK; Barber, LD; Prentice, HG; Lowdell, MW; (2001) Acute myeloid leukaemia cells secrete a soluble factor that inhibits T and NK cell proliferation but not cytolytic function - implications for the adoptive immunotherapy of leukaemia. CLIN EXP IMMUNOL , 126 (3) 403 - 411.

P

Pay, AL; Little, AM; Madrigal, JA; (2001) Donor selection in allogeneic bone marrow transplantation. In: Carella, AG and Daley, GQ and Eaves, CJ and Goldman, JM and Hehlmann, R, (eds.) Chronic Myeloid Leukaemia Biology and Treatment. (pp. 421-250). Martin Dunitz Ltd: London.

Peggs, K; Craddock, C; Milligan, D; Chopra, R; Mahendra, P; Chakraverty, R; Hunter, A; ... Mackinnon, S; + view all (2001) Non-myeloablative allogeneic transplantation for high-risk acute leukemia and myelodysplasia. In: BLOOD. (pp. 410A - 411A). AMER SOC HEMATOLOGY

Peggs, K; D'Sa, S; Kyriacou, C; Thuraisundaram, D; Williams, C; Goldstone, A; Mackinnon, S; (2001) Non-myeloablative allogeneic transplantation as front-line treatment for multiple myeloma: Response rates to conditioning and subsequent donor lymphocyte infusions. In: BLOOD. (pp. 419A - 419A). AMER SOC HEMATOLOGY

Peggs, K; Kottaridis, P; Morris, E; Kyriacou, C; Geary, J; Yong, K; Goldstone, A; ... Mackinnon, S; + view all (2001) Escalating dose donor lymphocyte infusions following non-myeloablative allogeneic transplantation are associated with minimal toxicity with sibling donors but a significant risk of severe GVHD with unrelated donors. In: BLOOD. (pp. 672A - 672A). AMER SOC HEMATOLOGY

Peggs, K; Verfuerth, S; Mackinnon, S; (2001) Induction of cytomegalovirus (CMV)-specific T-cell responses using dendritic cells pulsed with CMV antigen: a novel culture system free of live CMV virions. BLOOD , 97 (4) 994 - 1000.

Peggs, K; Verfuerth, S; Pizzey, A; Khan, N; Moss, P; Mackinnon, S; (2001) Cytomegalovirus-specific adoptive cellular therapy results in massive and persistent expansions of CMV-specific T-cells and significantly reduces the incidence of CMV reactivation following allogeneic transplantation. In: BLOOD. (pp. 779A - 779A). AMER SOC HEMATOLOGY

Peggs, KS; (2001) Exploiting graft-versus-tumour responses using donor leukocyte infusions. BEST PRACT RES CL HA , 14 (4) 723 - 739. 10.1053/beha.2001.0169.

Peggs, KS; Mackinnon, S; (2001) Cellular therapy: donor lymphocyte infusion. CURR OPIN HEMATOL , 8 (6) 349 - 354.

Peggs, KS; Mackinnon, S; (2001) Cytomegalovirus infection and disease after autologous peripheral blood stem cell transplantation. BRIT J HAEMATOL , 115 (4) 1032 - 1033.

Plunkett, FJ; Soares, MVD; Annels, N; Hislop, A; Ivory, K; Lowdell, M; Salmon, M; ... Akbar, AN; + view all (2001) The flow cytometric analysis of telomere length in antigen-specific CD8(+) T cells during acute Epstein-Barr virus infection. BLOOD , 97 (3) 700 - 707.

Porakishvili, N; Roschupkina, T; Kalber, T; Jewell, AP; Patterson, K; Yong, K; Lydyard, PM; (2001) Expansion of CD4<sup>+</sup> T cells with a cytotoxic phenotype in patients with B-chronic lymphocytic leukaemia (B-CLL). Clinical and Experimental Immunology , 126 (1) pp. 29-36. 10.1046/j.1365-2249.2001.01639.x.

Porter, JB; (2001) Deferoxamine pharmacokinetics. SEMINARS IN HEMATOLOGY , 38 (1) 63 - 68. 10.1053/shem.2001.20145.

Porter, JB; (2001) Deferoxamine pharmacokinetics. In: (pp. pp. 63-68).

Porter, JB; (2001) Practical management of iron overload. BRIT J HAEMATOL , 115 (2) 239 - 252.

Puar, U; Wickremasinghe, RG; Prentice, HG; Hoffbrand, AV; Mehta, AB; Ganeshaguru, K; (2001) Inhibitor of apoptosis XIAP expression in cells from B-CLL patients treated with DNA damaging agents. BLOOD , 98 (11) 181B - 182B.

Q

Quarmby, JW; Engelke, C; Chitolie, A; Morgan, RA; Belli, AM; (2001) Autologous thrombin-induced thrombosis of pseudoaneurysms. BRIT J SURG , 88 (4) 616 - 616.

R

Rafique, R.; Schapira, A.H.V.; Cooper, J.M.; (2001) Sensitivity of respiratory chain activities to lipid peroxidation: effect of vitamin E deficiency. Biochemical Journal , 357 (3) pp. 887-892. 10.1042/0264-6021:3570887.

Rai, R; Shlebak, A; Cohen, H; Backos, M; Holmes, Z; Marriott, K; Regan, L; (2001) Factor V Leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriage. HUM REPROD , 16 (5) 961 - 965.

Reynard, MP; Turner, D; Lowdell, M; Navarrete, CV; (2001) Cytokine gene polymorphisms associated with outcome of bone marrow transplantation. European Journal of Immunogenetics , 28 (2) 241-.

Robinson, J; Perez-Rodriguez, M; Waller, MJ; Cuillerier, B; Bahram, S; Yao, Z; Albert, ED; ... Marsh, SGE; + view all (2001) MICA sequences 2000. IMMUNOGENETICS , 53 (2) pp. 150-169. 10.1007/s002510100303.

Robinson, J; Waller, MJ; Parham, P; Bodmer, JG; Marsh, SGE; (2001) IMGT/HLA Database - a sequence database for the human major histocompatibility complex. NUCLEIC ACIDS RESEARCH , 29 (1) pp. 210-213. 10.1093/nar/29.1.210. Gold open access

Robinson, M; Machin, S; Mackie, I; Harrison, P; (2001) Comparison of glycocalicin, thrombopoietin and reticulated platelet measurement as markers of platelet turnover in HIV plus samples. PLATELETS , 12 (2) 108 - 113.

Rosette, C; Werlen, G; Daniels, MA; Holman, PO; Alam, SM; Travers, PJ; Gascoigne, NRJ; ... Jameson, SC; + view all (2001) The impact of duration versus extent of TCR occupancy on T cell activation: A revision of the kinetic proofreading model. Immunity , 15 (1) pp. 59-70.

S

Sarukhan, A; Soudais, C; Danos, O; Jooss, K; (2001) Factors influencing cross-presentation of non-self antigens expressed from recombinant adeno-associated virus vectors. J Gene Med , 3 (3) pp. 260-270. 10.1002/jgm.175.

Schreuder, GM; Hurley, CK; Marsh, SG; Lau, M; Maiers, M; Kollman, C; Noreen, HJ; (2001) The HLA Dictionary 2001: a summary of HLA-A, -B, -C, -DRB1/3/4/5 and -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens. Eur J Immunogenet , 28 (6) pp. 565-596.

Schreuder, GM; Hurley, CK; Marsh, SG; Lau, M; Maiers, M; Kollman, C; Noreen, HJ; (2001) The HLA Dictionary 2001: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens. Tissue Antigens , 58 (2) pp. 109-140.

Schreuder, GM; Hurley, CK; Marsh, SG; Lau, M; Maiers, M; Kollman, C; Noreen, HJ; (2001) The HLA dictionary 2001: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens. Hum Immunol , 62 (8) pp. 826-849.

Scurr, J.H.; Machin, S.J.; Bailey-King, S.; Mackie, I.J.; McDonald, S.; Coleridge Smith, P.D.; (2001) Frequency and prevention of symptomless deep-vein thrombosis in long-haul flights: a randomised trial. The Lancet , 357 (9267) pp. 1485-1489. 10.1016/S0140-6736(00)04645-6.

Scurr, JH; Machin, SJ; Bailey-King, S; Mackie, IJ; McDonald, S; Smith, PDC; (2001) Frequency and prevention of symptomless deep-vein thrombosis in long-haul flights: a randomised trial. LANCET , 357 (9267) 1485 - 1489.

Shaw, BE; Madrigal, JA; Potter, M; (2001) Improving the outcome of unrelated donor stem cell transplantation by molecular matching. BLOOD REV , 15 (4) 167 - 174. 10.1054/blre.2001.0163.

Shaw, BE; Pay, AL; Mayor, N; Potter, MN; Prentice, GH; Goldman, JM; Robinson, J; ... Madrigal, AJ; + view all (2001) High resolution molecular typing to ensure allele level matching for six highly polymorphic HLA antigens increases the overall survival in volunteer donor stem cell transplantation, however 'perfect' matches are found in only 10% of pairs. BLOOD , 98 (11) 668A - 668A.

Shaw, BE; Perry, D; Hoffbrand, AV; (2001) Progressive arterial thrombosis in a patient with non-Hodgkin's lymphoma, a lupus anticoagulant, factor V Leiden mutation and paraprotein, following chemotherapy. LEUKEMIA LYMPHOMA , 42 (1-2) 221 - 223.

Somervaille, TCP; Linch, DC; Khwaja, A; (2001) Growth factor withdrawal from primary human erythroid progenitors induces apoptosis through a pathway involving glycogen synthase kinase-3 and Bax. Blood , 98 (5) pp. 1374-1381. 10.1182/blood.V98.5.1374.

Somervaille, TCP; Linch, DC; Khwaja, A; (2001) Growth factor withdrawal from primary human erythroid progenitors induces apoptosis through a pathway involving glycogen synthase kinase-3 and Bax. BLOOD , 98 (5) 1374 - 1381.

Somervaille, TCP; Linch, DC; Khwaja, A; (2001) p38 MAP kinase regulates both differentiation and apoptosis in primary human erythroid cells. BLOOD , 98 (11) 78A - 79A.

Starke, R; Drummond, O; MacGregor, I; Biggerstaff, J; Camilleri, R; Gale, R; Lee, CA; ... Harrison, P; + view all (2001) Endothelial cells express and release soluble prion protein. BLOOD , 98 (11) 247A - 248A.

Stavrou, BM; Lawrence, C; Blackburn, GM; Cohen, T; Sheridan, DJ; Flores, NA; (2001) Coronary vasomotor and cardiac electrophysiologic effects of diadenosine polyphosphates and nonhydrolyzable analogs in the guinea pig. J Cardiovasc Pharmacol , 37 (5) pp. 571-584. 10.1097/00005344-200105000-00009.

Sweetenham, JW; Santini, G; Qian, W; Guelfi, M; Schmitz, N; Simnett, S; Nagler, A; ... Goldstone, AH; + view all (2001) High-dose therapy and autologous stem-cell transplantation versus conventional-dose consolidation/maintenance therapy as postremission therapy for adult patients with lymphoblastic lymphoma: results of a randomized trial of the European Group for Blood. Journal of Clinical Oncology , 19 (11) pp. 2927-2936.

Swerdlow, A.J.; Schoemaker, M.J.; Allerton, R.; Horwich, A.; Barber, J.A.; Cunningham, D.; Lister, T.A.; ... Linch, D.C.; + view all (2001) Lung cancer after Hodgkin’s disease: a nested case-control study of the relation to treatment. Journal of Clinical Oncology , 19 (6) pp. 1610-1618.

Swerdlow, AJ; Schoemaker, MJ; Allerton, R; Horwich, A; Barber, JA; Cunningham, D; Lister, TA; ... Linch, DC; + view all (2001) Lung cancer after Hodgkin's disease: A nested case-control study of the relation to treatment. J CLIN ONCOL , 19 (6) 1610 - 1618.

Szmania, S; Galloway, A; Bruorton, M; Musk, P; Aubert, G; Arthur, A; Pyle, H; ... Van Rhee, F; + view all (2001) Isolation and expansion of cytomegalovirus-specific cytotoxic T lymphocytes to clinical scale from a single blood draw using dendritic cells and HLA-tetramers. BLOOD , 98 (3) pp. 505-512.

T

Taylor, F; Cohen, H; Ebrahim, S; (2001) Long term anticoagulation or antiplatelet treatment - Reply. BRIT MED J , 323 (7306) 235 - 236.

Taylor, FC; Cohen, H; Ebrahim, S; (2001) Systematic review of long term anticoagulation or antiplatelet treatment in patients with non-rheumatic atrial fibrillation. BRIT MED J , 322 (7282) 321 - 326.

Thiselton, DL; Alexander, C; Morris, A; Brooks, S; Rosenberg, T; Eiberg, H; Kjer, B; ... Votruba, M; + view all (2001) A frameshift mutation in exon 28 of the OPA1 gene explains the high prevalence of dominant optic atrophy in the Danish population: evidence for a founder effect. HUM GENET , 109 (5) 498 - 502.

Truran, LN; Austin, SJ; Langabeer, SE; Kottaridis, PD; Linch, DC; Fisher, J; Burnett, AK; (2001) Quantitative bax and FLT3-ITD characterisation improve prognostic stratification in AML patients with intermediate risk cytogenetics. BLOOD , 98 (11) 578A - 578A.

U

Ulrich, S; Helmberg, W; Wagner, T; Corell, A; Marsh, SGE; Lanzer, G; (2001) A novel HLA-DRB1 sequence, DRB1*11272. TISSUE ANTIGENS , 57 (2) pp. 175-176. 10.1034/j.1399-0039.2001.057002175.x.

V

Vieira, SAD; Deininger, MWN; Sorour, A; Sinclair, P; Foroni, L; Goldman, JM; Melo, JV; (2001) Transcription factor BACH2 is transcriptionally regulated by the BCR/ABL oncogene. GENES CHROMOSOMES & CANCER , 32 (4) pp. 353-363. 10.1002/gcc.1200.

Vig, S; Chitolie, A; Bevan, DH; Halliday, A; Dormandy, J; (2001) Thromboelastography: a reliable test? BLOOD COAGUL FIBRIN , 12 (7) 555 - 561.

Vig, S; Chitolie, A; Maurice, E; Boa, F; Bevan, DH; Halliday, A; Dormandy, J; (2001) Poor outcome following revascularization predicted by thromboelastography. BRIT J SURG , 88 (4) 621 - 622.

Virchis, A; Massey, E; Butler, T; Devaraj, P; Wright, F; Secker-Walker, L; Prentice, HG; (2001) Acute myeloblastic leukaemias of FAB types M6 and M4, with cryptic PML/RAR alpha fusion gene formation, relapsing as acute promyelocytic leukaemia M3. British Journal of Haematology , 114 (3) pp. 551-556.

Vorechovsky, I; Kralovicova, J; Laycock, MD; Webster, ADB; Marsh, SGE; Madrigal, A; Hammarstrom, L; (2001) Short tandem repeat (STR) haplotypes in HLA: an integrated 50-kb STR/linkage disequilibrium/gene map between the RING3 and HLA-B genes and identification of STR haplotype diversification in the class III region. EUROPEAN JOURNAL OF HUMAN GENETICS , 9 (8) pp. 590-598. 10.1038/sj.ejhg.5200688.

von Messling, V; Fielding, A; Cattaneo, R; (2001) Of dogs and men: Canine distemper virus as model system for measles virus. GENE THERAPY , 8 S13-S13.

W

Watts, MJ; Ings, SJ; Ahmed, F; Smith, R; Mackinnon, S; Linch, DC; (2001) Clinical scale depletion of CD3+CD8+expressing T-cells from mobilised donor PBSC products using the eligix High Density Magnetic Particle (HDM) device. BONE MARROW TRANSPL , 27 S125 - S125.

Wedderburn, LR; Jeffery, R; White, H; Patel, A; Varsani, H; Linch, D; Murray, K; (2001) Autologous stem cell transplantation for paediatric-onset polyarteritis nodosa: changes in autoimmune phenotype in the context of reduced diversity of the T- and B-cell repertoires, and evidence for reversion from the CD45RO(+) to RA(+) phenotype. RHEUMATOLOGY , 40 (11) 1299 - 1307.

Wickremasinghe, RG; Ganeshaguru, K; Jones, DT; Lindsay, C; Spanswick, VJ; Hartley, JA; Wadhwa, M; ... Mehta, AB; + view all (2001) Autologous plasma activates Akt/protein kinase B and enhances basal survival and resistance to DNA damage-induced apoptosis in B-chronic lymphocytic leukaemia cells. BRIT J HAEMATOL , 114 (3) 608 - 615.

Wickremasinghe, RG; Ganeshaguru, K; Jones, DT; Lindsay, C; Spanswick, VJ; Hartley, JA; Wadhwa, M; ... Mehta, AB; + view all (2001) Autologous plasma activates Akt/protein kinase B and enhances basal survival and resistance to DNA damage-induced apoptosis in B-chronic lymphocytic leukaemia cells. Br J Haematol , 114 (3) pp. 608-615. 10.1046/j.1365-2141.2001.02978.x.

Wickremasinghe, RG; Jones, DT; Anderson, R; Prentice, HG; Mehta, AB; Hoffbrand, AV; Ganeshaguru, K; (2001) Plasma albumin activates the phosphatidylinositol-3 kinase/AKT signaling pathway and protects B-CLL cells from spontaneous and chlorambacil-induced apoptosis. BLOOD , 98 (11) 150A - 150A.

Y

Yee, TT; Murphy, K; Johnson, M; Abdalla, SH; Patton, GS; Lee, CA; Mehta, AB; (2001) Multiple myeloma and human immunodeficiency vivus-1 (HIV-1) infection. AMERICAN JOURNAL OF HEMATOLOGY , 66 (2) pp. 123-125. 10.1002/1096-8652(200102)66:2<123::AID-AJH1028>3.0.CO;2-P.

This list was generated on Sun Aug 18 05:04:09 2019 BST.